Neurobiological Technologies, Inc.
NTII
$0.00
$0.000.00%
OTC PK
12/17/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 0.00% | 10.15% | 11.33% | -7.35% | -17.27% |
Total Receivables | -- | 1,530.43% | -19.65% | 14.50% | 8.70% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -32.79% | 224.47% | -66.06% | 3.36% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -- | 21.01% | 11.92% | -7.85% | -16.91% |
|
|||||
Total Current Assets | -- | 21.01% | 11.92% | -7.85% | -16.91% |
Net Property, Plant & Equipment | -- | -48.57% | -33.96% | -19.70% | -61.85% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | 0.00% | -38.82% | 0.00% | 0.00% |
Total Assets | -- | 20.77% | -15.88% | -10.85% | -16.41% |
|
|||||
Total Accounts Payable | -- | -- | -94.55% | 5.19% | -29.21% |
Total Accrued Expenses | -- | -33.67% | -86.65% | -26.72% | 101.78% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -57.63% | -94.85% | 4.24% | -0.05% |
Total Other Current Liabilities | -- | -57.63% | -94.85% | 4.24% | -0.05% |
Total Current Liabilities | -- | -41.26% | -90.79% | -13.75% | 39.39% |
|
|||||
Total Current Liabilities | -- | -41.26% | -90.79% | -13.75% | 39.39% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -13.04% | -12.40% |
Total Liabilities | -- | -41.26% | -94.76% | -13.45% | 11.19% |
|
|||||
Common Stock & APIC | -- | 0.07% | 0.02% | 0.08% | 0.16% |
Retained Earnings | -- | 4.41% | 10.36% | -0.32% | -6.11% |
Treasury Stock & Other | -- | -- | -- | 3.53% | -3,217.07% |
Total Common Equity | 0.00% | 23.96% | 198.65% | -3.25% | -52.54% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | 0.00% | 0.00% | 0.00% | 0.00% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|||||
Total Common Equity | 0.00% | 23.96% | 198.65% | -3.25% | -52.54% |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 0.00% | 23.71% | 192.56% | -3.15% | -51.79% |
|